BrightSpring Health Services (NASDAQ:BTSG) Issues Earnings Results

Key Points

• Q1 beat: BrightSpring reported EPS of $0.39 vs. $0.32 expected and revenue of $3.61B (+25.6% YoY), with adjusted EBITDA $190M (+45% YoY), a 5.3% adjusted EBITDA margin and $123M operating cash flow.
• Business momentum and balance‑sheet action: Specialty & infusion revenue was $2.6B (+36% YoY) and provider revenue was $442M (+28% YoY, home health +49%), the company sold its community living business for ~$811M to reduce leverage and raised 2026 guidance to $14.725B–$15.225B revenue and $795M–$825M adjusted EBITDA.
• Regulatory headwinds remain material: Management expects roughly $600M of total pressure from IRA and brand‑to‑generic conversions (about $175M impacting home & community pharmacy this year) with only $15M of EBITDA mitigation assumed.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) released its earnings results on Friday. The company reported $0.39 earnings per share for the quarter, beating analysts' consensus estimates of $0.32 by $0.07, Briefing.com reports. The firm had revenue of $3.61 billion for the quarter, compared to analysts' expectations of $3.39 billion. BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. The company's quarterly revenue was up 25.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.14 earnings per share.

Here are the key takeaways from BrightSpring Health Services' conference call:

• Q1 financials — Total revenue was $3.6 billion (+26% YoY) with adjusted EBITDA of $190 million (+45% YoY) and a 5.3% adjusted EBITDA margin (up ~70 bps); operating cash flow was $123 million.
• Pharmacy solutions momentum — Specialty & infusion revenue was $2.6 billion (+36% YoY) with ~30% specialty script growth, four new exclusive/ultra-narrow LDDs added (total 153 LDDs), double‑digit infusion growth and new concierge programs like IG Connect.
• Provider services growth & quality — Provider revenue of $442 million (+28% YoY) included home health at $266 million (+49%), with acquired branches contributing ~$79 million of revenue and ~$9 million of adjusted EBITDA in Q1; quality metrics (91% of branches 4+ stars, >99% timely initiation) remain strong.
• Regulatory and conversion headwinds — Home & community pharmacy revenue declined 9% in Q1; management expects ~ $175M full‑year IRA impact to that business and previously cited roughly $181M (IRA specialty) plus ~$250M of brand‑to‑generic pressure (~$600M total headwind), with a $15M EBITDA mitigation unchanged.
• Balance sheet & guidance — Sold community living for ~$811M (pre‑tax) to strengthen the balance sheet, reducing leverage to 2.27x (pro forma 2.40x); 2026 guidance (ex‑community living) targets $14.725B–$15.225B revenue and $795M–$825M adjusted EBITDA, which includes ~ $30M expected contribution from acquired Amedisys/LHC assets.

BrightSpring Health Services Price Performance

Shares of NASDAQ:BTSG traded up $4.61 during trading on Friday, reaching $52.58. The company had a trading volume of 9,470,421 shares, compared to its average volume of 2,014,496. The company has a fifty day moving average of $43.50 and a two-hundred day moving average of $38.72. The stock has a market capitalization of $10.16 billion, a P/E ratio of 46.12, a price-to-earnings-growth ratio of 0.68 and a beta of 1.72. BrightSpring Health Services has a 12 month low of $19.01 and a 12 month high of $54.68. The company has a current ratio of 1.57, a quick ratio of 1.12 and a debt-to-equity ratio of 1.32.

Insider Transactions at BrightSpring Health Services

In related news, insider Jon B. Rousseau sold 220,000 shares of the stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total transaction of $9,053,000.00. Following the transaction, the insider owned 1,023,880 shares of the company's stock, valued at approximately $42,132,662. This trade represents a 17.69% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Lisa A. Nalley sold 30,000 shares of the stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total transaction of $1,234,500.00. Following the transaction, the insider directly owned 110,594 shares in the company, valued at approximately $4,550,943.10. This represents a 21.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 285,000 shares of company stock valued at $11,727,750 in the last quarter. Insiders own 2.80% of the company's stock.

Hedge Funds Weigh In On BrightSpring Health Services

Several institutional investors and hedge funds have recently made changes to their positions in BTSG. EverSource Wealth Advisors LLC bought a new position in shares of BrightSpring Health Services during the 2nd quarter valued at $43,000. Los Angeles Capital Management LLC bought a new position in shares of BrightSpring Health Services during the 4th quarter valued at $115,000. Sandia Investment Management LP bought a new position in shares of BrightSpring Health Services during the 2nd quarter valued at $118,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of BrightSpring Health Services by 1,371.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,120 shares of the company's stock valued at $192,000 after purchasing an additional 4,772 shares during the last quarter. Finally, PEAK6 LLC bought a new position in shares of BrightSpring Health Services during the 4th quarter valued at $206,000.

More BrightSpring Health Services News

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Q1 results beat street estimates — EPS of $0.39 topped consensus (~$0.32) and revenue of $3.61B beat estimates (~$3.39B); revenue was up ~25.6% year‑over‑year, signaling healthy top‑line growth. Quarterly results and call
• Positive Sentiment: Company raised full‑year 2026 revenue and adjusted EBITDA guidance (management increased its FY revenue range to roughly $14.7B–$15.2B), which supports the rally and suggests management confidence in demand and margins. BrightSpring extends rally with upgraded forecast
• Positive Sentiment: Street recognition — BTSG was added to Zacks’ top growth (Rank #1) list, which can support additional retail/institutional interest. Zacks Rank #1 inclusion
• Neutral Sentiment: Investor materials available — management hosted a call and posted a press release and slide deck with more detail on results and guidance for investors to evaluate execution and forward assumptions. Press release and slides
• Negative Sentiment: Valuation and leverage remain considerations — BTSG trades at a high P/E (~60) with a beta >2 and debt/equity ~1.32; strong results improve the story but raise expectations that the company must sustain growth to justify the valuation.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on BTSG shares. Morgan Stanley boosted their target price on shares of BrightSpring Health Services from $40.00 to $48.00 and gave the company an "overweight" rating in a research note on Wednesday, March 4th. BTIG Research reiterated a "buy" rating and issued a $55.00 target price on shares of BrightSpring Health Services in a research note on Thursday, March 19th. Mizuho boosted their target price on shares of BrightSpring Health Services from $50.00 to $52.00 and gave the company an "outperform" rating in a research note on Wednesday, March 18th. TD Cowen reiterated a "buy" rating on shares of BrightSpring Health Services in a research note on Monday, March 2nd. Finally, Wells Fargo & Company boosted their target price on shares of BrightSpring Health Services from $43.00 to $50.00 and gave the company an "overweight" rating in a research note on Monday, March 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $46.50.

BrightSpring Health Services Company Profile

BrightSpring Health Services NASDAQ: BTSG is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company's operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient's home environment, fostering independence and improving quality of life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.